Skip to main content
Top
Published in: Supportive Care in Cancer 10/2020

01-10-2020 | Anxiety | Original Article

The association between health-related quality of life and achievement of personalized symptom goal

Authors: Keita Tagami, Takashi Kawaguchi, Tomofumi Miura, Takuhiro Yamaguchi, Yoshihisa Matsumoto, Yuki Sumazaki Watanabe, Yuko Uehara, Ayumi Okizaki, Akira Inoue, Tatsuya Morita, Hiroya Kinoshita

Published in: Supportive Care in Cancer | Issue 10/2020

Login to get access

Abstract

Purpose

The aim of study was to explore the potential association between patient’s self-reported physical symptom management goals as personalized symptom goal (PSGs) and health-related quality of life (HRQOL) in cancer patients. The secondary outcome was to investigate the relationship between number of physical symptoms not achieving the PSGs and HRQOL in cancer patients.

Methods

This single-center prospective observational study comprised 140 consecutive outpatients. We evaluated the PSGs and HRQOL using the Functional Assessment of Cancer Therapy–General (FACT-G). Patients were administered a self-report questionnaire, including reports on their physical symptom intensity and PSGs using Edmonton Symptom Assessment System-revised (ESAS-r) scores. We investigated the correlation between PSGs achievement (ESAS-r score ≤ PSG score) and FACT-G total scores, and relationship between and number of physical symptoms not achieving the PSGs (ESAS-r score > PSG score) and FACT-G total scores.

Results

The patients who did not achieve PSGs of pain, tiredness, lack of appetite, and shortness of breath had a lower FACT-G total score (p < 0.05). Multivariate linear regression showed that higher number of physical symptoms not achieving the PSGs correlated with lower FACT-G scores (decreasing by 1.826 points for each such symptom, p < 0.01). Predictors of increased number of physical symptoms not achieving the PSGs were younger age and a higher symptom intensity of anxiety.

Conclusion

PSGs achievement was associated with HRQOL in cancer patients. Additionally, the number of unachieved PSGs were independent determinant of poor HRQOL, particularly in younger cancer patients and those with higher symptom intensity of anxiety.
Literature
1.
go back to reference Omran S, McMillan S (2018) Symptom severity, anxiety, depression, self-efficacy and quality of life in patients with cancer. Asian Pac J Cancer Prev 19:365–374PubMedPubMedCentral Omran S, McMillan S (2018) Symptom severity, anxiety, depression, self-efficacy and quality of life in patients with cancer. Asian Pac J Cancer Prev 19:365–374PubMedPubMedCentral
2.
go back to reference Laird BJ, Fallon M, Hjermstad MJ, Tuck S, Kaasa S, Klepstad P, McMillan DC (2016) Quality of life in patients with advanced cancer: differential association with performance status and systemic inflammatory response. J Clin Oncol 34:2769–2775CrossRef Laird BJ, Fallon M, Hjermstad MJ, Tuck S, Kaasa S, Klepstad P, McMillan DC (2016) Quality of life in patients with advanced cancer: differential association with performance status and systemic inflammatory response. J Clin Oncol 34:2769–2775CrossRef
3.
go back to reference McMillan SC, Small BJ (2002) Symptom distress and quality of life in patients with cancer newly admitted to hospice home care. Oncol Nurs Forum 29:1421–1428CrossRef McMillan SC, Small BJ (2002) Symptom distress and quality of life in patients with cancer newly admitted to hospice home care. Oncol Nurs Forum 29:1421–1428CrossRef
4.
go back to reference Omran S, Khader Y, McMillan S (2017) Symptom clusters and quality of life in hospice patients with cancer. Asian Pac J Cancer Prev 18:2387–2393PubMedPubMedCentral Omran S, Khader Y, McMillan S (2017) Symptom clusters and quality of life in hospice patients with cancer. Asian Pac J Cancer Prev 18:2387–2393PubMedPubMedCentral
5.
go back to reference Hui D, Park M, Shamieh O, Paiva CE, Perez-Cruz PE, Muckaden MA, Bruera E (2016) Personalized symptom goals and response in patients with advanced cancer. Cancer 122:1774–1781CrossRef Hui D, Park M, Shamieh O, Paiva CE, Perez-Cruz PE, Muckaden MA, Bruera E (2016) Personalized symptom goals and response in patients with advanced cancer. Cancer 122:1774–1781CrossRef
6.
go back to reference Hui D, Bruera E (2014) A personalized approach to assessing and managing pain in patients with cancer. J Clin Oncol 32:1640–1646CrossRef Hui D, Bruera E (2014) A personalized approach to assessing and managing pain in patients with cancer. J Clin Oncol 32:1640–1646CrossRef
7.
go back to reference Dalal S, Hui D, Nguyen L, Chacko R, Scott C, Roberts L, Bruera E (2012) Achievement of personalized pain goal in cancer patients referred to a supportive care clinic at a comprehensive cancer center. Cancer 118:3869–3877CrossRef Dalal S, Hui D, Nguyen L, Chacko R, Scott C, Roberts L, Bruera E (2012) Achievement of personalized pain goal in cancer patients referred to a supportive care clinic at a comprehensive cancer center. Cancer 118:3869–3877CrossRef
8.
go back to reference Arthur J, Tanco K, Park M, Haider A, Maligi C, Dalal S, Naqvi SMA, Liu D, Bruera E (2018) Personalized pain goal as an outcome measure in routine cancer pain assessment. J Pain Symptom Manag 56:80–87CrossRef Arthur J, Tanco K, Park M, Haider A, Maligi C, Dalal S, Naqvi SMA, Liu D, Bruera E (2018) Personalized pain goal as an outcome measure in routine cancer pain assessment. J Pain Symptom Manag 56:80–87CrossRef
9.
go back to reference Watanabe YS, Miura T, Okizaki A, Tagami K, Matsumoto Y, Fujimori M, Morita T, Kinoshita H (2018) Comparison of indicators for achievement of pain control with a personalized pain goal in a comprehensive cancer center. J Pain Symptom Manag 55:1159–1164CrossRef Watanabe YS, Miura T, Okizaki A, Tagami K, Matsumoto Y, Fujimori M, Morita T, Kinoshita H (2018) Comparison of indicators for achievement of pain control with a personalized pain goal in a comprehensive cancer center. J Pain Symptom Manag 55:1159–1164CrossRef
10.
go back to reference Zylla D, Larson A, Chuy G, Illig L, Peck A, Van Peursem S, Fulbright JW, Pawloski PA, Richter S, Mettner J (2017) Establishment of personalized pain goals in oncology patients to improve care and decrease costs. J Oncol Pract 13:e266–e272CrossRef Zylla D, Larson A, Chuy G, Illig L, Peck A, Van Peursem S, Fulbright JW, Pawloski PA, Richter S, Mettner J (2017) Establishment of personalized pain goals in oncology patients to improve care and decrease costs. J Oncol Pract 13:e266–e272CrossRef
11.
go back to reference Bruera E, Kuehn N, Miller MJ, Selmser P, Macmillan K (1991) The Edmonton symptom assessment system (ESAS): a simple method for the assessment of palliative care patients. J Palliat Care 7:6–9CrossRef Bruera E, Kuehn N, Miller MJ, Selmser P, Macmillan K (1991) The Edmonton symptom assessment system (ESAS): a simple method for the assessment of palliative care patients. J Palliat Care 7:6–9CrossRef
12.
go back to reference Watanabe SM, Nekolaichuk C, Beaumont C, Johnson L, Myers J, Strasser F (2011) A multicenter study comparing two numerical versions of the Edmonton symptom assessment system in palliative care patients. J Pain Symptom Manag 41:456–468CrossRef Watanabe SM, Nekolaichuk C, Beaumont C, Johnson L, Myers J, Strasser F (2011) A multicenter study comparing two numerical versions of the Edmonton symptom assessment system in palliative care patients. J Pain Symptom Manag 41:456–468CrossRef
13.
go back to reference Watanabe SM, Nekolaichuk CL, Beaumont C (2012) The Edmonton symptom assessment system, a proposed tool for distress screening in cancer patients: development and refinement. Psychooncology 21:977–985CrossRef Watanabe SM, Nekolaichuk CL, Beaumont C (2012) The Edmonton symptom assessment system, a proposed tool for distress screening in cancer patients: development and refinement. Psychooncology 21:977–985CrossRef
14.
go back to reference Yokomichi N, Morita T, Nitto A, Takahashi N, Miyamoto S, Nishie H, Matsuoka J, Sakurai H, Ishihara T, Mori M, Tarumi Y, Ogawa A (2015) Validation of the Japanese version of the Edmonton symptom assessment system-revised. J Pain Symptom Manag 50:718–723CrossRef Yokomichi N, Morita T, Nitto A, Takahashi N, Miyamoto S, Nishie H, Matsuoka J, Sakurai H, Ishihara T, Mori M, Tarumi Y, Ogawa A (2015) Validation of the Japanese version of the Edmonton symptom assessment system-revised. J Pain Symptom Manag 50:718–723CrossRef
15.
go back to reference Miura T, Matsumoto Y, Kawaguchi T, Masuda Y, Okizaki A, Koga H, Tagami K, Watanabe YS, Uehara Y, Yamaguchi T, Morita T (2019) Low phase angle is correlated with worse general condition in patients with advanced cancer. Nutr Cancer 71(1):83–88CrossRef Miura T, Matsumoto Y, Kawaguchi T, Masuda Y, Okizaki A, Koga H, Tagami K, Watanabe YS, Uehara Y, Yamaguchi T, Morita T (2019) Low phase angle is correlated with worse general condition in patients with advanced cancer. Nutr Cancer 71(1):83–88CrossRef
16.
go back to reference Knotkova H, Fine PG, Portenoy RK (2009) Opioid rotation: the science and the limitations of the equianalgesic dose table. J Pain Symptom Manag 38(3):426–439CrossRef Knotkova H, Fine PG, Portenoy RK (2009) Opioid rotation: the science and the limitations of the equianalgesic dose table. J Pain Symptom Manag 38(3):426–439CrossRef
17.
go back to reference Fumimoto H, Kobayashi K, Chang CH, Eremenco S, Fujiki Y, Uemura S, Ohashi Y, Kudoh S (2001) Cross-cultural validation of an international questionnaire, the general measure of the Functional Assessment of Cancer Therapy scale (FACT-G), for Japanese. Qual Life Res 10:701–709CrossRef Fumimoto H, Kobayashi K, Chang CH, Eremenco S, Fujiki Y, Uemura S, Ohashi Y, Kudoh S (2001) Cross-cultural validation of an international questionnaire, the general measure of the Functional Assessment of Cancer Therapy scale (FACT-G), for Japanese. Qual Life Res 10:701–709CrossRef
18.
go back to reference Oldenmenger WH, de Raaf PJ, de Klerk C, van der Rijt CC (2013) Cut points on 0–10 numeric rating scales for symptoms included in the Edmonton symptom assessment scale in cancer patients: a systematic review. J Pain Symptom Manag 45:1083–1093CrossRef Oldenmenger WH, de Raaf PJ, de Klerk C, van der Rijt CC (2013) Cut points on 0–10 numeric rating scales for symptoms included in the Edmonton symptom assessment scale in cancer patients: a systematic review. J Pain Symptom Manag 45:1083–1093CrossRef
19.
go back to reference Walsh D, Donnelly S, Rybicki L (2000) The symptoms of advanced cancer: relationship to age, gender, and performance status in 1,000 patients. Support Care Cancer 8:175–179CrossRef Walsh D, Donnelly S, Rybicki L (2000) The symptoms of advanced cancer: relationship to age, gender, and performance status in 1,000 patients. Support Care Cancer 8:175–179CrossRef
20.
go back to reference McFarland DC, Shaffer KM, Tiersten A, Holland J (2018) Prevalence of physical problems detected by the distress thermometer and problem list in patients with breast cancer. Psychooncology 27:1394–1403CrossRef McFarland DC, Shaffer KM, Tiersten A, Holland J (2018) Prevalence of physical problems detected by the distress thermometer and problem list in patients with breast cancer. Psychooncology 27:1394–1403CrossRef
21.
go back to reference Mohile SG, Heckler C, Fan L, Mustian K, Jean-Pierre P, Usuki K, Sprod L, Janelsins M, Purnell J, Peppone L, Palesh O, Devine KA, Morrow G (2011) Age-related differences in symptoms and their interference with quality of life in 903 cancer patients undergoing radiation therapy. J Geriatr Oncol 2:225–232CrossRef Mohile SG, Heckler C, Fan L, Mustian K, Jean-Pierre P, Usuki K, Sprod L, Janelsins M, Purnell J, Peppone L, Palesh O, Devine KA, Morrow G (2011) Age-related differences in symptoms and their interference with quality of life in 903 cancer patients undergoing radiation therapy. J Geriatr Oncol 2:225–232CrossRef
22.
go back to reference Hopwood P, Stephens RJ (2000) Depression in patients with lung cancer: prevalence and risk factors derived from quality-of-life data. J Clin Oncol 18:893–903CrossRef Hopwood P, Stephens RJ (2000) Depression in patients with lung cancer: prevalence and risk factors derived from quality-of-life data. J Clin Oncol 18:893–903CrossRef
23.
go back to reference Lloyd-Williams M, Dennis M, Taylor F (2004) A prospective study to determine the association between physical symptoms and depression in patients with advanced cancer. Palliat Med 18:558–563CrossRef Lloyd-Williams M, Dennis M, Taylor F (2004) A prospective study to determine the association between physical symptoms and depression in patients with advanced cancer. Palliat Med 18:558–563CrossRef
24.
go back to reference Visser MR, Smets EM (1998) Fatigue, depression and quality of life in cancer patients: how are they related? Support Care Cancer 6:101–108CrossRef Visser MR, Smets EM (1998) Fatigue, depression and quality of life in cancer patients: how are they related? Support Care Cancer 6:101–108CrossRef
Metadata
Title
The association between health-related quality of life and achievement of personalized symptom goal
Authors
Keita Tagami
Takashi Kawaguchi
Tomofumi Miura
Takuhiro Yamaguchi
Yoshihisa Matsumoto
Yuki Sumazaki Watanabe
Yuko Uehara
Ayumi Okizaki
Akira Inoue
Tatsuya Morita
Hiroya Kinoshita
Publication date
01-10-2020
Publisher
Springer Berlin Heidelberg
Published in
Supportive Care in Cancer / Issue 10/2020
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-020-05316-0

Other articles of this Issue 10/2020

Supportive Care in Cancer 10/2020 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine